Wellcome Trust Case Control Consortium

Overview WTCCC3 studies
WTCCC3 studies
Anorexia Nervosa Host control of HIV-1 Renal Transplant Dysfunction Pre-Eclampsia Primary Biliary Cirrhosis
Press & publications
Press Release: 28/09/2005 Press Release: 06/06/2007 Publications and presentations
Data access
Access to data Approved Applications CDAC members Data formats FAQ
Open access
Available software
Participant access
Participant Login
Feedback and queries

Susceptibility Genes for Pre-Eclampsia in UK women

Dr Linda Morgan

Anna F Dominiczak, Mark Caulfield, Martin Farrall, James Walker.

Pre-eclampsia, a disorder of pregnancy associated with high blood pressure, causes 900,000 infant deaths and 40,000 maternal deaths worldwide annually. Pre-eclampsia runs in families, and recent advances in technology enable testing of all human genes in a single experiment. DNA from 2,225 UK women affected by pre-eclampsia will be tested. Results will be double-checked by retesting selected genes in DNA collections from 2500 women affected by pre-eclampsia from Norway and Finland, together with 2500 control samples from healthy pregnant women. Knowing which genes predispose to pre-eclampsia will improve understanding of its causes, and assist in developing strategies for its prevention and treatment.